Harvey Homan
CEO,
MetasTx, LLC
United States
Dr. Homan led the formation of MetasTx, LLC with Drs. Somanath Shenoy and Brian Cummings in 08/21, and started MetasTx on the road to potential breakthroughs that may revolutionize prevention and treatment of arising metastatic cancer. As Founder and CEO of biotech and medical device companies in USA and UK he has achieved successful marketing authorization, commercialization and exits, and extensive experience transitioning technology from academic labs to businesses. For Sterling Health and The Boots Company (BHI), he led growth of businesses in consumer-focused pharmaceuticals and has led commercialization of hundreds of successful products. At Sterling, he rapidly progressed to lead R&D, regulatory and clinical affairs for Europe, led global Analgesic, GI, and Skin Care portfolios and instituted innovative product development organizations and processes. Dr. Homan led all scientific, medical, regulatory and development functions for Boots Healthcare International (BHI) globally. He was responsible for development of partnerships in Europe, U.S., India and Japan that built BHI to £500 million revenue and a £2 billion exit sale As Head of Corporate Development and Innovation he led and coached Directors in value creation through innovation. He has a PhD from UGA and a MBA from NYU Stern.
Suffix
PhD
Sessions
-
10-Feb-2025MetasTx, LLC
)
){kind=logo}
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}